Mounting evidence suggests that SCUBE2 acts as a tumor suppressor in breast cancer [16, 17], non small cell lung cancer (NSCLC) [18], colorectal cancer [19] and gastric cancer [20]. Here, SCUBE2 is linked to breast carcinoma.